tepmetko
merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
mig pentru copii suspensie orala 20 mg/ml
berlin-chemie ag (menarini group) - ibuprofenum - suspensie orala - 20 mg/ml
priorix-tetra
glaxo smithkline biologicals s.a. - belgia - vaccin rujeolic,rubeolic,urlian,varicelic,viu. - pulb+solv.pt.sol.inj. in seringa preumpluta - vaccinuri virale vaccinuri rujeolice
priorix-tetra
glaxosmithkline biologicals sa - belgia - vaccin rujeolic,rubeolic,urlian,varicelic,viu. - pulb. si solv. pt. sol. inj. in seringa preumpluta - vaccinuri virale vaccinuri rujeolice
aminazin solutie injectabila 25 mg/ml
zdorovie narodu srl, if din harkov - chlorpromazinum - solutie injectabila - 25 mg/ml
relium comprimate filmate 5 mg
polfa sa, tarchomin - diazepamum - comprimate filmate - 5 mg
tegretol comprimate 200 mg
novartis pharma ag - carbamazepinum - comprimate - 200 mg
validol comprimate sublinguale 60 mg
farmak sap - mentholum in menthylisovaleratum - comprimate sublinguale - 60 mg
zostavax
merck sharp & dohme b.v. - virusul varicelo-zoster (viu, atenuat) - herpes zoster; immunization - vaccinuri virale - zostavax este indicat pentru prevenirea herpes zoster (zoster sau herpes zoster) și a nevralgiei postherpetice legate de herpes zoster. zostavax este indicat pentru imunizarea persoanelor cu vârsta de 50 ani sau mai în vârstă.